InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (2 oper.)
▼ Ventas (3 oper.)
Historial del iniciado
Director FinancieroCompras declaradas
2
Ventas declaradas
3
Tasa de acierto T+90
0%
Rendimiento medio T+90
-25.1%
Sobre 1 señal de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Explore the complete record of transactions filed by Emany Sravan Kumar, Director Financiero. Insider active across 4 companies, notably Ironwood Pharmaceuticals INC. In total, 20 disclosures have been published. Breakdown: 2 buys · 3 sells. Total volume traded: €636k. History available since 6 December 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Emany Sravan Kumar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones20 en total
23.855 títulosCommon StockSEC:0001104659-26-074749:0
31.750 títulos0Common StockSEC:0001193125-26-140513:0
11.006 títulos0Common StockSEC:0001193125-26-076897:0
6294 títulos@ 27,10 US$100.0% de su flujoCommon StockSEC:0001193125-26-002448:0
53.750 títulos0Common StockSEC:0001104659-25-046868:0
80.000 títulos0Common StockSEC:0000950170-25-000624:0
11.001 títulos@ 4,08 US$3.5% de su flujoClass A Common StockSEC:0000950170-24-129227:0
53.750 títulos0Common StockSEC:0001104659-24-065701:0
18.280 títulos@ 6,64 US$9.1% de su flujoClass A Common StockSEC:0000950170-24-062372:0
37.120 títulos0Class A Common StockSEC:0000950170-24-029907:0
10.684 títulos@ 9,38 US$7.5% de su flujoClass A Common StockSEC:0000950170-24-027128:0
Salida canónica: 2 jun 2024 (T+90)
65.312 títulos0Class A Common StockSEC:0000950170-24-015545:0
41.332 títulos@ 14,90 US$46.4% de su flujoClass A Common StockSEC:0000950170-24-013817:0
85.000 títulos0Class A Common StockSEC:0001209191-24-001903:0
6661 títulos@ 9,44 US$4.7% de su flujoClass A Common StockSEC:0001209191-23-056023:0
177.570 títulos0Common StockSEC:0001104659-23-119212:0
36.072 títulos@ 8,32 US$68.2% de su flujoClass A Common StockSEC:0001209191-23-049781:0
Salida canónica: 14 dic 2023 (T+90)
74.236 títulos0Class A Common StockSEC:0001209191-23-017878:0
6578 títulos@ 11,56 US$6.0% de su flujoClass A Common StockSEC:0001209191-22-058611:0
85.000 títulos0Class A Common StockSEC:0001209191-21-068513:0
20 de 20 declaraciones
About Emany Sravan Kumar
Emany Sravan Kumar is Chief Financial Officer. He has 20 filings in total, and across the 20 sampled recent filings, the reported amounts are EUR 374569 of buys and EUR 261413 of sells, with activity ranging from 2021-12-08 to 2026-06-16. The largest filings concern Ironwood Pharmaceuticals INC and Beam Therapeutics Inc., and the modal transaction nature is Attribution.
